158 related articles for article (PubMed ID: 15235029)
1. Genetic susceptibility in familial melanoma from northeastern Italy.
Landi MT; Goldstein AM; Tsang S; Munroe D; Modi W; Ter-Minassian M; Steighner R; Dean M; Metheny N; Staats B; Agatep R; Hogg D; Calista D
J Med Genet; 2004 Jul; 41(7):557-66. PubMed ID: 15235029
[No Abstract] [Full Text] [Related]
2. Genetic and environmental factors in cutaneous malignant melanoma.
Bressac-de-Paillerets B; Avril MF; Chompret A; Demenais F
Biochimie; 2002 Jan; 84(1):67-74. PubMed ID: 11900878
[TBL] [Abstract][Full Text] [Related]
3. Genes involved in melanoma: an overview of INK4a and other loci.
Castellano M; Parmiani G
Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
Soufir N; Avril MF; Chompret A; Demenais F; Bombled J; Spatz A; Stoppa-Lyonnet D; Bénard J; Bressac-de Paillerets B
Hum Mol Genet; 1998 Feb; 7(2):209-16. PubMed ID: 9425228
[TBL] [Abstract][Full Text] [Related]
5. A review of inherited predisposition to melanoma.
Cannon-Albright LA; Kamb A; Skolnick M
Semin Oncol; 1996 Dec; 23(6):667-72. PubMed ID: 8970585
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
Celebi JT; Ward KM; Wanner M; Polsky D; Kopf AW
Clin Exp Dermatol; 2005 Jan; 30(1):68-70. PubMed ID: 15663508
[TBL] [Abstract][Full Text] [Related]
10. Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy.
Menin C; Vecchiato A; Scaini MC; Elefanti L; Funari G; De Salvo GL; Quaggio M; Tognazzo S; Agata S; Dalla Santa S; Montagna M; Alaibac M; Chiarion-Sileni V; D'Andrea E
Pigment Cell Melanoma Res; 2011 Aug; 24(4):728-30. PubMed ID: 21672182
[No Abstract] [Full Text] [Related]
11. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
[TBL] [Abstract][Full Text] [Related]
12. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M
Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
Laud K; Marian C; Avril MF; Barrois M; Chompret A; Goldstein AM; Tucker MA; Clark PA; Peters G; Chaudru V; Demenais F; Spatz A; Smith MW; Lenoir GM; Bressac-de Paillerets B;
J Med Genet; 2006 Jan; 43(1):39-47. PubMed ID: 15937071
[TBL] [Abstract][Full Text] [Related]
14. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
Gruis NA; Van der Velden PA; Bergman W; Frants RR
Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
[TBL] [Abstract][Full Text] [Related]
15. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
[TBL] [Abstract][Full Text] [Related]
16. [Of mice and humans. Updates on susceptibility and tumor suppression of malignant melanoma].
Hautarzt; 2002 Jan; 53(1):88-9. PubMed ID: 11968172
[No Abstract] [Full Text] [Related]
17. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of familial cutaneous melanoma.
Haluska FG; Hodi FS
J Clin Oncol; 1998 Feb; 16(2):670-82. PubMed ID: 9469357
[TBL] [Abstract][Full Text] [Related]
20. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
